Article info
PDFOccasional viewpoint
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
- Correspondence to:
A K Burroughs, Liver Transplantation and Hepatobiliary Medicine, Royal Free Hospital NHS Trust, Pond Street, London NW3 2QG, UK;
andrew.burroughs{at}talk21.com
Citation
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Publication history
- Accepted May 15, 2001
- First published March 1, 2002.
Online issue publication
January 10, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Gut